Share What, Why & How
Share to email
Share to Facebook
Share to X
By Iowa Pharmacy Association
4
33 ratings
The podcast currently has 51 episodes available.
On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, to discuss her many roles within the Department of Inspections, Appeals, & Licensing (DIAL), as well as the timeline for the new Board of Pharmacy rules pursuant to Governor Reynolds’ Executive Order #10 and HF 555.
Anne Schlepphorst serves as the Executive Director of the Iowa Board of Pharmacy, Interim Executive Director of the Iowa Board of Nursing, and Monitoring Bureau Chief. In addition to serving the Boards of Pharmacy and Nursing, Anne truly enjoys spending time working with staff to provide some of the best professional health programming in the country for health professionals struggling with mental health, substance abuse, and/or health-related impairments. Anne has worked with the boards for the past six years and was most recently the Chief Investigator for the Iowa Boards of Pharmacy and Medicine. When not working, Anne and her husband spend most of their time at the baseball field, hockey rink, wrestling mat, or football field watching their 10- and 14-year-old boys.
Resources from today’s episode:
Connect with us on LinkedIn:
On this episode of IPA’s What, Why & How podcast, Seth Brown welcomes Representative John Forbes, RPh, District 44, to discuss the outcome of the 2024 Legislative Session and IPA’s continued efforts toward our legislative priorities.
Connect with us on LinkedIn:
Watch for the next episode of the What, Why & How podcast on the third Friday of the month. Subscribe today so you don’t miss an episode!
On this episode of IPA’s What, Why & How podcast, Seth Brown welcomes Andria Seip, J.D., M.S., Senior Health Policy Specialist with the Iowa Insurance Division (IID), to discuss the data collected through PBM complaints by Iowa pharmacists and IID’s focus going forward.
Connect with us on LinkedIn:
Watch for the next episode of the What, Why & How podcast on the third Friday of the month. Subscribe today so you don’t miss an episode!
On this episode of IPA’s What, Why & How podcast, Seth Brown welcomes IPA lobbyist Kate Walton of Eide-Walton Lobbying and Government Relations. Kate describes the current makeup of the Iowa Legislature as we head into the 2024 Legislative Session.
Connect with us on LinkedIn:
Watch for the next episode of the What, Why & How podcast on the third Friday of the month. Subscribe today so you don’t miss an episode!
For the final episode of 2023, IPA’s Seth Brown welcomes Michael Baxter, Vice President of Federal Government Affairs at the American Pharmacists Association (APhA), to discuss direct and indirect remuneration (DIR) fees and the Medicare Part D Final Rule going into effect January 1, 2024.
Following the August 29 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Iowa's state government realignment and what it means for the Board of Pharmacy.
Following the May 2 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Executive Agency rulemaking and Executive Order #10.
Following the February 28 Iowa Board of Pharmacy meeting, IPA staff welcomes special guest Mitch Barnett, Associate Director of the Prescription Monitoring Program (PMP) at the Board of Pharmacy, to discuss the Board’s Disposal Kit Dispensing Program.
Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.
On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session. No CE available.
The podcast currently has 51 episodes available.